A carregar...
Publicação
Tissue structure developer: jellyfish-based collagen as an innovative wound healing treatment - business model, funding & exit strategies
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 8.76 MB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
TSD, a novel biotech venture, aims to revolutionise the wound healing market by utilising
jellyfish, a new source of collagen. Its product, the CollaPatchTM, harnesses the benefits of
jellyfish collagen across social, environmental, and ecological dimensions, offering a superior
alternative to bovine- and porcine-based collagen products for wound healing.
This paper introduces the product with its scientific work, analyses the stakeholders and the
competitive environment of the product and presents a detailed business model. It then outlines
the funding requirements, targeted sources of funding and exit strategies.
Descrição
Palavras-chave
Biotechnology Biomedical innovation Business strategy Intellectual property Pharmaceutical Competitive analysis Funding Ulcers Wound healing Chronical wounds Jellyfish Marine collagen Venture capital Intrapreneurship Entrepreneurship